We are pleased to announce that two FCA portfolio companies were recently featured on David William's Health Business Blog podcast.
To succeed in value based care, providers must reduce unwarranted variance in utilization and cost. Medical devices and drugs are good places to focus, since they represent big slices of the spending pie that are rarely optimized. In this podcast interview, Lumere CEO Hani Elias describes how his company deploys evidence based software and services to help health system clients take on variation.
- (0:12)What are some of the key challenges in healthcare?
- (1:31) What do you mean by “unwarranted” variation?
- (2:45) Are you able to tell which variation is appropriate and which is not?
- (4:30) How does the decision making process differ between drugs and devices?
- (6:42) Drug and device companies are large and are influential with physicians. How do you operate effectively in that environment?
- (8:45) How do you differentiate from others who work on reducing cost and improving quality?
- (10:30) What’s new, and what’s the same in this administration in Washington compared to the prior one?
- (11:41) The company has a new name. Why?
- (12:35) What does the future hold for Lumere?
Patient payments are a real friction point in the US healthcare system. Patients don’t understand what they owe, and doctors usually can’t help them figure it out. HealthiPASS is doing its best to solve these problems with a consumer-friendly approach that pays off financially for providers.
In this podcast interview, HealthiPASS CEO, Rajesh Voddiraju answers my questions about how it all works.
- (0:17 )What are the problems with patient payments today?
- (2:40) What have physician offices been doing about it about it? How successful are those efforts?
- (6:30) How does HealthiPASS work?
- (11:50) With the four steps it sounds like you are allowing the physician office to educate the patient about the extent of their financial obligations under high deductible plans. Is that right?
- (13:09) How does the system interact with existing practice management systems? What is the impact on the office workflow?
- (18:51)The value proposition for physician offices is pretty clear, but what about for patients? Is it in a patient’s interest to use this system?
- (21:37) What are you doing to increase adoption?
- (26:08) How do you expect the market to evolve?